$KRMD
KORU Medical Systems, Inc.

2024 Q3 Form 10-Q Financial Statement

#000116169724000334 Filed on August 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $8.180M $8.430M
YoY Change 16.8% 21.54%
Cost Of Revenue $2.994M $2.950M
YoY Change 12.51% -3.2%
Gross Profit $5.186M $5.480M
YoY Change 19.43% 40.94%
Gross Profit Margin 63.4% 65.0%
Selling, General & Admin $5.128M $5.320M
YoY Change 10.89% 0.31%
% of Gross Profit 98.88% 97.08%
Research & Development $1.534M $1.134M
YoY Change 18.6% -28.96%
% of Gross Profit 29.58% 20.7%
Depreciation & Amortization $227.8K $217.9K
YoY Change 5.45% 2.32%
% of Gross Profit 4.39% 3.98%
Operating Expenses $6.889M $6.672M
YoY Change 12.33% -6.2%
Operating Profit -$1.703M -$1.192M
YoY Change -4.9% -63.03%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $122.5K $203.3K
YoY Change -0.03% 57.99%
Pretax Income -$1.581M -$988.7K
YoY Change -5.26% -68.06%
Income Tax
% Of Pretax Income
Net Earnings -$1.581M -$988.7K
YoY Change 15.53% -60.39%
Net Earnings / Revenue -19.33% -11.73%
Basic Earnings Per Share -$0.03 -$0.02
Diluted Earnings Per Share -$0.03 -$0.02
COMMON SHARES
Basic Shares Outstanding 45.86M shares 45.76M shares
Diluted Shares Outstanding 45.85M shares 45.81M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $8.806M $10.46M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $3.928M $2.589M
Prepaid Expenses $955.2K $472.9K
Receivables $5.165M $5.846M
Other Receivables
Total Short-Term Assets $18.93M $19.37M
YoY Change -12.72% -14.09%
LONG-TERM ASSETS
Property, Plant & Equipment $4.552M $3.679M
YoY Change 19.16% -3.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $98.97K $98.97K
YoY Change 0.0% 0.0%
Total Long-Term Assets $8.461M $7.938M
YoY Change -38.09% -41.0%
TOTAL ASSETS
Total Short-Term Assets $18.93M $19.37M
Total Long-Term Assets $8.461M $7.938M
Total Assets $27.39M $27.30M
YoY Change -22.53% -24.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.670M $1.596M
YoY Change 76.64% 1.34%
Accrued Expenses $2.793M $2.145M
YoY Change 91.49% 57.43%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.324M $5.137M
YoY Change 49.78% 26.01%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.324M $5.137M
Total Long-Term Liabilities
Total Liabilities $9.657M $8.599M
YoY Change 21.87% 8.92%
SHAREHOLDERS EQUITY
Retained Earnings -$27.82M -$26.24M
YoY Change 75.55% 81.22%
Common Stock $49.43M $48.82M
YoY Change 4.91% 5.17%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.882M $3.882M
YoY Change 1.01% 1.01%
Treasury Stock Shares
Shareholders Equity $17.73M $18.70M
YoY Change
Total Liabilities & Shareholders Equity $27.39M $27.30M
YoY Change -22.53% -24.15%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$1.581M -$988.7K
YoY Change 15.53% -60.39%
Depreciation, Depletion And Amortization $227.8K $217.9K
YoY Change 5.45% 2.32%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
usd
CY2024Q2 us-gaap Deferred Rent Receivables Net Noncurrent
DeferredRentReceivablesNetNoncurrent
6581206 usd
CY2023Q4 us-gaap Deferred Rent Receivables Net Noncurrent
DeferredRentReceivablesNetNoncurrent
6002777 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
98970 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
98970 usd
CY2024Q2 us-gaap Assets
Assets
27303566 usd
CY2023Q4 us-gaap Assets
Assets
28460972 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1595691 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
975193 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2144722 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1711427 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
314344 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
447788 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
512520 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
444251 usd
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
112689 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
109540 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
391699 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
368313 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5136840 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4454278 usd
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
259479 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
316623 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3202697 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3336300 usd
CY2024Q2 us-gaap Liabilities
Liabilities
8599016 usd
CY2023Q4 us-gaap Liabilities
Liabilities
8107201 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49257812 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49089864 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45819286 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
492398 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
490899 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
47018707 usd
CY2023Q4 us-gaap Treasury Stock Preferred Shares
TreasuryStockPreferredShares
3438526 shares
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
3882493 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26236946 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23312273 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27303566 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28460972 usd
CY2024Q2 us-gaap Revenues
Revenues
8430089 usd
CY2023Q2 us-gaap Revenues
Revenues
6935931 usd
CY2024Q2 us-gaap Other Receivables
OtherReceivables
usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2024Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2023Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
usd
us-gaap Payments For Other Taxes
PaymentsForOtherTaxes
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y6M21D
CY2023Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P6Y10M17D
CY2024Q2 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P3Y2M19D
CY2023Q4 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P3Y8M19D
CY2024Q2 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
usd
CY2024Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
462941 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45669362 shares
CY2024Q2 us-gaap Treasury Stock Preferred Shares
TreasuryStockPreferredShares
3438526 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
18704550 usd
us-gaap Revenues
Revenues
16627887 usd
us-gaap Revenues
Revenues
14328536 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2950339 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3047807 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6044839 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6293377 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
5479750 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
3888124 usd
us-gaap Gross Profit
GrossProfit
10583048 usd
us-gaap Gross Profit
GrossProfit
8035159 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5319688 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5303167 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10677308 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10729044 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1134232 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1596614 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2609907 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3161483 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
217864 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
212919 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
449233 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
426036 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
6671784 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
7112700 usd
us-gaap Operating Expenses
OperatingExpenses
13736448 usd
us-gaap Operating Expenses
OperatingExpenses
14316563 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3224576 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3153400 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6281404 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-10680 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2472 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-22159 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3152 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-300 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-56279 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
213999 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
131167 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
251186 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
48331591 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3843562 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
20353771 usd
us-gaap Revenues
Revenues
16627887 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2950339 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3047807 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6044839 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6293377 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
5479750 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
3888124 usd
us-gaap Gross Profit
GrossProfit
10583048 usd
us-gaap Gross Profit
GrossProfit
8035159 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5319688 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5303167 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10677308 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10729044 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1134232 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3161483 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
217864 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
212919 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
449233 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
426036 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
6671784 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
7112700 usd
us-gaap Operating Expenses
OperatingExpenses
13736448 usd
us-gaap Operating Expenses
OperatingExpenses
14316563 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1192034 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3224576 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3153400 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6281404 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-10680 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2472 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-22159 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3152 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-300 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-56279 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
213999 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
131167 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
251186 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
256669 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
203319 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
128695 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
228727 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
197238 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-988715 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3095881 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2924673 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6084166 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-599995 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1177395 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-988715 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2495886 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
256669 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
203319 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
128695 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
228727 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
197238 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-988715 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3095881 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2924673 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6084166 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-599995 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1177395 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-988715 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2495886 usd
us-gaap Net Income Loss
NetIncomeLoss
-2924673 usd
us-gaap Net Income Loss
NetIncomeLoss
-4906771 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45811373 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45606603 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45761799 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45547427 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45811373 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45606603 shares
us-gaap Net Income Loss
NetIncomeLoss
-2924673 usd
us-gaap Net Income Loss
NetIncomeLoss
-4906771 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1314384 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1681955 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
449233 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
426036 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1177395 usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-300 usd
krmd Noncash Lease Adjustments
NoncashLeaseAdjustments
-10994 usd
krmd Noncash Lease Adjustments
NoncashLeaseAdjustments
-10994 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1800871 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
239590 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-892551 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1126643 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-774313 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-687994 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-64731 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
5916 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-817169 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-18691 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-119776 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
433296 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1527648 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-335385 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4814520 usd
us-gaap Net Income Loss
NetIncomeLoss
-2924673 usd
us-gaap Net Income Loss
NetIncomeLoss
-4906771 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45811373 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45606603 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45761799 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45547427 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45811373 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45606603 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45761799 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45547427 shares
us-gaap Net Income Loss
NetIncomeLoss
-2924673 usd
us-gaap Net Income Loss
NetIncomeLoss
-4906771 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1314384 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1681955 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
449233 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
426036 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1177395 usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-300 usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-56279 usd
krmd Noncash Lease Adjustments
NoncashLeaseAdjustments
-10994 usd
krmd Noncash Lease Adjustments
NoncashLeaseAdjustments
-10994 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1800871 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
239590 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-892551 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1126643 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-774313 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-687994 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-64731 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
5916 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
620498 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-817169 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-18691 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-119776 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
433296 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1527648 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-335385 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4814520 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
257367 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
375246 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
24216 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
17298 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-281583 usd
krmd Payments On Indebtedness
PaymentsOnIndebtedness
314344 usd
krmd Payments On Indebtedness
PaymentsOnIndebtedness
433295 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
53995 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
48493 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
257367 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
375246 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
24216 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
17298 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-281583 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-392544 usd
krmd Payments On Indebtedness
PaymentsOnIndebtedness
314344 usd
krmd Payments On Indebtedness
PaymentsOnIndebtedness
433295 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
53995 usd
us-gaap Payments For Other Taxes
PaymentsForOtherTaxes
38932 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-407271 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-481788 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1024239 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5688852 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17408257 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10458001 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11719405 usd
us-gaap Interest Paid Net
InterestPaidNet
20491 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3160 usd
krmd Issuance Of Common Stock Compensation
IssuanceOfCommonStockCompensation
221182 usd
krmd Issuance Of Common Stock Compensation
IssuanceOfCommonStockCompensation
266023 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
20353771 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
123804 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
393113 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
130676 usd
CY2024Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
52125 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1935958 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
19117531 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-988715 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
18704550 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
175776 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
170387 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2410885 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
29796300 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
90247 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
540099 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
170387 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2495886 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
28101147 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_84C_eus-gaap--NatureOfOperations_zuNRR9X8WuT5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_zL58AmV7DqSg">NATURE OF OPERATIONS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">KORU MEDICAL SYSTEMS, INC. (the “Company,” “KORU Medical,” “we,” “us” or “our”) designs, manufactures and markets proprietary portable and innovative medical devices primarily for the subcutaneous drug delivery market as governed by the United States Food and Drug Administration (the “FDA”) quality and regulatory system and international regulations and standards for quality system management. The Company operates as <span id="xdx_903_eus-gaap--NumberOfReportableSegments_dxH_uN_c20240101__20240630_zgmsm6zH8i9" title="Number of segment::XDX::1">one</span> segment.</p>
us-gaap Payments For Other Taxes
PaymentsForOtherTaxes
38932 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-407271 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-481788 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1024239 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11482240 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17408257 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10458001 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11719405 usd
us-gaap Interest Paid Net
InterestPaidNet
20491 usd
us-gaap Interest Paid Net
InterestPaidNet
20165 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3160 usd
krmd Issuance Of Common Stock Compensation
IssuanceOfCommonStockCompensation
221182 usd
krmd Issuance Of Common Stock Compensation
IssuanceOfCommonStockCompensation
266023 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
123804 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
393113 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
130676 usd
CY2024Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
52125 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1935958 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
19117531 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
97500 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
401218 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
63984 usd
CY2024Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
13032 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-988715 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
18704550 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
31325963 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
175776 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
535059 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
170387 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2410885 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
29796300 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
90247 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
540099 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
170387 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2495886 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
28101147 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_84C_eus-gaap--NatureOfOperations_zuNRR9X8WuT5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_860_zL58AmV7DqSg">NATURE OF OPERATIONS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">KORU MEDICAL SYSTEMS, INC. (the “Company,” “KORU Medical,” “we,” “us” or “our”) designs, manufactures and markets proprietary portable and innovative medical devices primarily for the subcutaneous drug delivery market as governed by the United States Food and Drug Administration (the “FDA”) quality and regulatory system and international regulations and standards for quality system management. The Company operates as <span id="xdx_903_eus-gaap--NumberOfReportableSegments_dxH_uN_c20240101__20240630_zgmsm6zH8i9" title="Number of segment::XDX::1">one</span> segment.</p>
us-gaap Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
10500000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zwBJwuyIaRwk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_867_zXdhu3aGikK9">USE OF ESTIMATES IN THE FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with United States generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Important estimates include but are not limited to asset lives, deferred tax valuation allowances, inventory valuation, expected credit losses, and customer rebate and incentive accruals. The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results that may be expected for the entire 2024 fiscal year.</p>
us-gaap Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
10500000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zwBJwuyIaRwk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_867_zXdhu3aGikK9">USE OF ESTIMATES IN THE FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with United States generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Important estimates include but are not limited to asset lives, deferred tax valuation allowances, inventory valuation, expected credit losses, and customer rebate and incentive accruals. The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results that may be expected for the entire 2024 fiscal year.</p>
krmd Schedule Of Net Sales By Geography
ScheduleOfNetSalesByGeography
<p id="xdx_89B_ecustom--ScheduleOfNetSalesByGeography_zDNyTfMVxHZc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BB_zofRxwMyRalc">The following table summarizes net revenues by geography for the three and six months ended June 30, 2024, and 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="5" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Three Months Ended June 30,</b></span></td> <td style="text-align: center"> </td> <td colspan="5" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Six Months Ended June 30,</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2024</b></span></td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2023</b></span></td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2024</b></span></td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2023</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 26%"><span style="font-size: 10pt"><b>Revenues</b></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right"> </td> <td style="width: 4%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right"> </td> <td style="width: 4%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right"> </td> <td style="width: 4%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #E6E6E6"> <td><span style="font-size: 10pt">Domestic</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td id="xdx_984_eus-gaap--Revenues_c20240401__20240630__srt--StatementGeographicalAxis__country--US_zyo69OUvvJ5j" style="text-align: right" title="Net Revenue"><span style="font-size: 10pt">6,779,298</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--Revenues_c20230401__20230630__srt--StatementGeographicalAxis__country--US_z9CjehkkJHR3" style="text-align: right" title="Net Revenue"><span style="font-size: 10pt">5,686,427</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td id="xdx_987_eus-gaap--Revenues_c20240101__20240630__srt--StatementGeographicalAxis__country--US_zhI8cYN2wt8f" style="text-align: right" title="Net Revenue"><span style="font-size: 10pt">13,163,381</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--Revenues_c20230101__20230630__srt--StatementGeographicalAxis__country--US_zaQs26aVnKM2" style="text-align: right" title="Net Revenue"><span style="font-size: 10pt">11,970,392</span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt">International</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_988_eus-gaap--Revenues_c20240401__20240630__srt--StatementGeographicalAxis__us-gaap--NonUsMember_z5w5jSSHlrbj" style="border-bottom: black 1pt solid; text-align: right" title="Net Revenues"><span style="font-size: 10pt">1,650,791</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_984_eus-gaap--Revenues_c20230401__20230630__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zBQYpPP8dyA1" style="border-bottom: black 1pt solid; text-align: right" title="Net Revenues"><span style="font-size: 10pt">1,249,504</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_980_eus-gaap--Revenues_c20240101__20240630__srt--StatementGeographicalAxis__us-gaap--NonUsMember_z4HCir5gCE74" style="border-bottom: black 1pt solid; text-align: right" title="Net Revenues"><span style="font-size: 10pt">3,464,506</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98E_eus-gaap--Revenues_c20230101__20230630__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zsnS5IHk2qr4" style="border-bottom: black 1pt solid; text-align: right" title="Net Revenues"><span style="font-size: 10pt">2,358,144</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #E6E6E6"> <td><span style="font-size: 10pt"><b>Total</b></span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--Revenues_c20240401__20240630_zRfM2Aa7Yhbi" style="border-bottom: black 2.25pt double; text-align: right" title="Revenues"><span style="font-size: 10pt">8,430,089</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--Revenues_c20230401__20230630_zIeWl5jXJlnb" style="border-bottom: black 2.25pt double; text-align: right" title="Revenues"><span style="font-size: 10pt">6,935,931</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-size: 10pt">$</span></td> <td id="xdx_984_eus-gaap--Revenues_c20240101__20240630_zKQ01HE5dxW1" style="border-bottom: black 2.25pt double; text-align: right" title="Revenues"><span style="font-size: 10pt">16,627,887</span></td> <td style="border-bottom: white 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double"><span style="font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--Revenues_c20230101__20230630_zHrOoWkT9RD1" style="border-bottom: black 2.25pt double; text-align: right" title="Revenues"><span style="font-size: 10pt">14,328,536</span></td> <td> </td></tr> </table>
CY2024Q2 us-gaap Revenues
Revenues
8430089 usd
CY2023Q2 us-gaap Revenues
Revenues
6935931 usd
us-gaap Revenues
Revenues
16627887 usd
us-gaap Revenues
Revenues
14328536 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6558930 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3133881 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2721273 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3678984 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3837657 usd
CY2024Q2 us-gaap Depreciation
Depreciation
217864 usd
us-gaap Depreciation
Depreciation
449233 usd
us-gaap Depreciation
Depreciation
426036 usd
krmd Schedule Of Net Sales By Geography
ScheduleOfNetSalesByGeography
<p id="xdx_89B_ecustom--ScheduleOfNetSalesByGeography_zDNyTfMVxHZc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BB_zofRxwMyRalc">The following table summarizes net revenues by geography for the three and six months ended June 30, 2024, and 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="5" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Three Months Ended June 30,</b></span></td> <td style="text-align: center"> </td> <td colspan="5" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Six Months Ended June 30,</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2024</b></span></td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2023</b></span></td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2024</b></span></td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>2023</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 26%"><span style="font-size: 10pt"><b>Revenues</b></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right"> </td> <td style="width: 4%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right"> </td> <td style="width: 4%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right"> </td> <td style="width: 4%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #E6E6E6"> <td><span style="font-size: 10pt">Domestic</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td id="xdx_984_eus-gaap--Revenues_c20240401__20240630__srt--StatementGeographicalAxis__country--US_zyo69OUvvJ5j" style="text-align: right" title="Net Revenue"><span style="font-size: 10pt">6,779,298</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--Revenues_c20230401__20230630__srt--StatementGeographicalAxis__country--US_z9CjehkkJHR3" style="text-align: right" title="Net Revenue"><span style="font-size: 10pt">5,686,427</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td id="xdx_987_eus-gaap--Revenues_c20240101__20240630__srt--StatementGeographicalAxis__country--US_zhI8cYN2wt8f" style="text-align: right" title="Net Revenue"><span style="font-size: 10pt">13,163,381</span></td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td id="xdx_980_eus-gaap--Revenues_c20230101__20230630__srt--StatementGeographicalAxis__country--US_zaQs26aVnKM2" style="text-align: right" title="Net Revenue"><span style="font-size: 10pt">11,970,392</span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt">International</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_988_eus-gaap--Revenues_c20240401__20240630__srt--StatementGeographicalAxis__us-gaap--NonUsMember_z5w5jSSHlrbj" style="border-bottom: black 1pt solid; text-align: right" title="Net Revenues"><span style="font-size: 10pt">1,650,791</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_984_eus-gaap--Revenues_c20230401__20230630__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zBQYpPP8dyA1" style="border-bottom: black 1pt solid; text-align: right" title="Net Revenues"><span style="font-size: 10pt">1,249,504</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_980_eus-gaap--Revenues_c20240101__20240630__srt--StatementGeographicalAxis__us-gaap--NonUsMember_z4HCir5gCE74" style="border-bottom: black 1pt solid; text-align: right" title="Net Revenues"><span style="font-size: 10pt">3,464,506</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98E_eus-gaap--Revenues_c20230101__20230630__srt--StatementGeographicalAxis__us-gaap--NonUsMember_zsnS5IHk2qr4" style="border-bottom: black 1pt solid; text-align: right" title="Net Revenues"><span style="font-size: 10pt">2,358,144</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #E6E6E6"> <td><span style="font-size: 10pt"><b>Total</b></span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--Revenues_c20240401__20240630_zRfM2Aa7Yhbi" style="border-bottom: black 2.25pt double; text-align: right" title="Revenues"><span style="font-size: 10pt">8,430,089</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--Revenues_c20230401__20230630_zIeWl5jXJlnb" style="border-bottom: black 2.25pt double; text-align: right" title="Revenues"><span style="font-size: 10pt">6,935,931</span></td> <td> </td> <td style="border-bottom: black 2.25pt double"><span style="font-size: 10pt">$</span></td> <td id="xdx_984_eus-gaap--Revenues_c20240101__20240630_zKQ01HE5dxW1" style="border-bottom: black 2.25pt double; text-align: right" title="Revenues"><span style="font-size: 10pt">16,627,887</span></td> <td style="border-bottom: white 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double"><span style="font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--Revenues_c20230101__20230630_zHrOoWkT9RD1" style="border-bottom: black 2.25pt double; text-align: right" title="Revenues"><span style="font-size: 10pt">14,328,536</span></td> <td> </td></tr> </table>
CY2024Q2 us-gaap Revenues
Revenues
8430089 usd
CY2023Q2 us-gaap Revenues
Revenues
6935931 usd
us-gaap Revenues
Revenues
16627887 usd
us-gaap Revenues
Revenues
14328536 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6812865 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6558930 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3133881 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3678984 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3837657 usd
CY2024Q2 us-gaap Depreciation
Depreciation
217864 usd
CY2023Q2 us-gaap Depreciation
Depreciation
212919 usd
us-gaap Depreciation
Depreciation
449233 usd
us-gaap Depreciation
Depreciation
426036 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
112806 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
112279 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
224354 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
224801 usd
CY2024Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
556 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
4016 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
78037 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
113362 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
137422 usd
us-gaap Lease Cost
LeaseCost
228370 usd
us-gaap Lease Cost
LeaseCost
302838 usd
CY2024Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
28896 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
27224 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
57793 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
54447 usd
CY2024Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
5671 usd
CY2023Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
6387 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
112806 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
112279 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
224354 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
224801 usd
CY2024Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
556 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
25143 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
4016 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
78037 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
113362 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
137422 usd
us-gaap Lease Cost
LeaseCost
228370 usd
us-gaap Lease Cost
LeaseCost
302838 usd
CY2024Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
28896 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
27224 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
57793 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
54447 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
11724 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
11724 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
13107 usd
CY2024Q2 krmd Finance Lease Cost
FinanceLeaseCost
34567 usd
CY2023Q2 krmd Finance Lease Cost
FinanceLeaseCost
33611 usd
krmd Finance Lease Cost
FinanceLeaseCost
69517 usd
krmd Finance Lease Cost
FinanceLeaseCost
67554 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
244879 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
229879 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
65718 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
61600 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3514055 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
391699 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3336300 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3594396 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3704613 usd
CY2024Q2 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
577929 usd
CY2023Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
577929 usd
CY2024Q2 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
219254 usd
CY2023Q4 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
161461 usd
CY2023Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
416468 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
109540 usd
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
259479 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
316623 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
426163 usd
CY2024Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0660 pure
CY2023Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0576 pure
CY2024Q2 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.0625 pure
CY2023Q4 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.0619 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
266990 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
65718 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
533979 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
131437 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
533979 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
131437 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
13107 usd
CY2024Q2 krmd Finance Lease Cost
FinanceLeaseCost
34567 usd
CY2023Q2 krmd Finance Lease Cost
FinanceLeaseCost
33611 usd
krmd Finance Lease Cost
FinanceLeaseCost
69517 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
244879 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
229879 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
65718 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
61600 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3414831 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3514055 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
391699 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
368313 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3202697 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3336300 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3594396 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3704613 usd
CY2023Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
577929 usd
CY2024Q2 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
219254 usd
CY2023Q4 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
161461 usd
CY2024Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
358675 usd
CY2023Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
416468 usd
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
112689 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
109540 usd
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
259479 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
316623 usd
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
372168 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
426163 usd
CY2024Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0660 pure
CY2023Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0576 pure
CY2024Q2 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.0625 pure
CY2023Q4 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.0619 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
266990 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
65718 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
533979 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
131437 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
533979 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
131437 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
533979 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
74194 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
520985 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
6180 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1833603 usd
CY2024Q2 krmd Lessee Operating Lease Liability Payments Due Total
LesseeOperatingLeaseLiabilityPaymentsDueTotal
4223515 usd
CY2024Q2 krmd Lessee Financing Lease Lease Liability Payments Due Total
LesseeFinancingLeaseLeaseLiabilityPaymentsDueTotal
408966 usd
CY2024Q2 krmd Lessee Operating Lease Imputed Interest
LesseeOperatingLeaseImputedInterest
629119 usd
CY2024Q2 krmd Lessee Financing Lease Imputed Interest
LesseeFinancingLeaseImputedInterest
36799 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3594396 usd
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
372168 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
599995 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1177395 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6002777 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6581206 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
533979 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
74194 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
6180 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1833603 usd
CY2024Q2 krmd Lessee Operating Lease Liability Payments Due Total
LesseeOperatingLeaseLiabilityPaymentsDueTotal
4223515 usd
CY2024Q2 krmd Lessee Operating Lease Imputed Interest
LesseeOperatingLeaseImputedInterest
629119 usd
CY2024Q2 krmd Lessee Financing Lease Imputed Interest
LesseeFinancingLeaseImputedInterest
36799 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3594396 usd
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
372168 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
599995 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6581206 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001161697-24-000334-index-headers.html Edgar Link pending
0001161697-24-000334-index.html Edgar Link pending
0001161697-24-000334.txt Edgar Link pending
0001161697-24-000334-xbrl.zip Edgar Link pending
ex_31-1.htm Edgar Link pending
ex_31-2.htm Edgar Link pending
ex_32-1.htm Edgar Link pending
ex_32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form_10-q.htm Edgar Link pending
krmd-20240630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
krmd-20240630_cal.xml Edgar Link unprocessable
krmd-20240630_def.xml Edgar Link unprocessable
krmd-20240630_lab.xml Edgar Link unprocessable
krmd-20240630_pre.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
form_10-q_htm.xml Edgar Link completed